Related Experiment Video

Updated: May 5, 2026

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on: July 12, 2018

7.9K

Biocon's first-in-class anti-CD6 mAb reaches the market

Killugudi Jayaraman

    Nature Biotechnology
    |December 10, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
    12:36

    Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

    Published on: June 26, 2018

    8.7K
    In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
    07:25

    In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

    Published on: May 4, 2017

    17.0K

    Related Experiment Videos

    Last Updated: May 5, 2026

    A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
    11:13

    A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

    Published on: July 12, 2018

    7.9K
    Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
    12:36

    Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

    Published on: June 26, 2018

    8.7K
    In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
    07:25

    In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

    Published on: May 4, 2017

    17.0K

    Related Concept Videos

    Drug Products: Biologics, Biosimilars and Interchangeables01:28

    Drug Products: Biologics, Biosimilars and Interchangeables

    369
    Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
    369
    Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

    Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

    880
    Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
    880

    Articles linked to this work by shared authors, journal, and citation graph.

    Precise genomic integration of large DNA fragments by donor-directed annealing using prime editing.

    Nature biotechnology·2026

    Donor-complementary prime editing enables precise kilobase and library-compatible DNA insertions.

    Nature biotechnology·2026

    Megascale microbiome analysis with DartUniFrac.

    Nature biotechnology·2026

    Engineered bacterial siderophore production accelerates rock weathering for carbon removal.

    Nature biotechnology·2026

    Transferable genetic toolsets for nonmodel gut Clostridia enable in vivo reversible control of metabolite production.

    Nature biotechnology·2026

    Adaptive model-guided protein evolution with sparse data optimizes compact eukaryotic genome editors.

    Nature biotechnology·2026

    Can Telehealth Improve Access to Amyloid-Targeting Therapies for Veterans Living With Alzheimer Disease?

    Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026

    Correction to: Sustained release microneedle patch for pronounced systemic delivery of doxazosin mesylate.

    BioImpacts : BI·2026

    A Nomogram Integrating Clinical and Cardiac Imaging for Predicting Short-Term Left Ventricular Ejection Fraction Decline in Patients with Duchenne Muscular Dystrophy.

    International journal of general medicine·2026

    Metformin modulates the phenotypes of tumor-associated macrophages in glioblastoma in a context-dependent manner by promoting the homeostasis of macrophages.

    Frontiers in oncology·2026

    OAF Blocks SIAH1-Mediated Degradation of SCPX, a Therapeutic Strategy for MASLD.

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

    Real World Data and Its Impact on the Management of Plasma Cell Dyscrasias.

    Current hematologic malignancy reports·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us